Is Peppermint Functional Dyspepsia Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Peppermint Functional Dyspepsia Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - The S1 guideline summarizes the current state of knowledge and allows a targeted approach based on the currently available medical evidence. [Storr M (2026); evidence level 2] - Functional dyspepsia (FD) is common and classified as a disorder of gut-brain interaction (DGBI). [Storr M (2026); evidence level 2] - Diagnosis is based on symptoms, which are classified according to the Rome IV criteria, in combination with diagnostic procedures that may include laboratory testing, Helicobacter pylori testing, upper gastrointestinal endoscopy, abdominal ultrasound, and other examinations, depending on the severity, duration, and presence of alarm symptoms. [Storr M (2026); evidence level 2] - Low-grade intestinal inflammation with increased mast cells has been observed in some IBS cohorts., A dysbiotic or less diverse gut microbiome may be present in IBS, and small intestinal bacterial overgrowth occurs in a subset of patients; however, routine testing is not of clinical value. [Morrison Savannah (2026); evidence level 3] - 4 Many studies support a strong psychosocial foundation for IBS, particularly seen in patients who report higher levels of daily stress and those with increased anxiety, depression, and somatic symptoms.There is often a genetic predisposition for IBS. [Morrison Savannah (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.